本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

1.60
-0.0100-0.62%
盤後1.55-0.0472-2.95%19:57 EDT
成交量:99.17萬
成交額:157.26萬
市值:3,626.07萬
市盈率:-0.12
高:1.62
開:1.55
低:1.55
收:1.61
52周最高:10.99
52周最低:1.24
股本:2,266.29萬
流通股本:1,577.42萬
量比:0.50
換手率:6.29%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-47.61%
市淨率:-0.11
市盈率(LYR):-0.09

資料載入中...

2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 5.02
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/09

重要事件披露

Current report, items 8.01 and 9.01
2019/11/18

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/09/16

重要事件披露

Current report, items 1.01 and 9.01